Table of Contents Author Guidelines Submit a Manuscript
Advances in Hematology
Volume 2010, Article ID 896161, 8 pages
http://dx.doi.org/10.1155/2010/896161
Research Article

Photodynamic Therapy with the Silicon Phthalocyanine Pc 4 Induces Apoptosis in Mycosis Fungoides and Sezary Syndrome

1Department of Dermatology, University Hospitals of Cleveland, Case Western Reserve University, 11100 Euclid Avenue, Lakeside 3500, Cleveland, OH 44106-5028, USA
2Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China
3Department of Radiation Oncology, Case Western Reserve University, 10900 Euclid Ave., Cleveland, OH 44106-4942, USA
4Dermatology Department, Cleveland Veterans Affairs Medical Center, Cleveland, OH 44106, USA

Received 6 July 2010; Revised 2 September 2010; Accepted 14 October 2010

Academic Editor: Christian Peschel

Copyright © 2010 Minh Lam et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. K. Lee, E. D. Baron, and T. H. Foster, “Monitoring Pc 4 photodynamic therapy in clinical trials of cutaneous T-cell lymphoma using noninvasive spectroscopy,” Journal of Biomedical Optics, vol. 13, no. 3, Article ID 030507, pp. 1–3, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Garcia-Zuazaga, K. D. Cooper, and E. D. Baron, “Photodynamic therapy in dermatology: current concepts in the treatment of skin cancer,” Expert Review of Anticancer Therapy, vol. 5, no. 5, pp. 791–800, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. S.-I. Moriwaki, J. Misawa, Y. Yoshinari, I. Yamada, M. Takigawa, and Y. Tokura, “Analysis of photosensitivity in Japanese cancer-bearing patients receiving photodynamic therapy with porfimer sodium (Photofrin),” Photodermatology Photoimmunology and Photomedicine, vol. 17, no. 5, pp. 241–243, 2001. View at Google Scholar · View at Scopus
  4. S. Ahmadi, P. A. McCarron, R. F. Donnelly, A. D. Woolfson, and K. McKeena, “Evaluation of the penetration of 5-aminolevulinic acid through basal cell carcinoma: a pilot study,” Experimental Dermatology, vol. 13, no. 7, pp. 445–451, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. N. L. Oleinick, A. R. Antunez, M. E. Clay, B. D. Rihter, and M. E. Kenney, “New phthalocyanine photosensitizers for photodynamic therapy,” Photochemistry and Photobiology, vol. 57, no. 2, pp. 242–247, 1993. View at Google Scholar · View at Scopus
  6. N. S. Trivedi, H.-W. Wang, A.-L. Nieminen, N. L. Oleinick, and J. A. Izatt, “Quantitative analysis of Pc 4 localization in mouse lymphoma (LY-R) cells via double-label confocal fluorescence microscopy,” Photochemistry and Photobiology, vol. 71, no. 5, pp. 634–639, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Lam, N. L. Oleinick, and A.-L. Nieminen, “Photodynamic therapy-induced apoptosis in epidermoid carcinoma cells: reactive oxygen species and mitochondrial inner membrane permeabilization,” Journal of Biological Chemistry, vol. 276, no. 50, pp. 47379–47386, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. T.-W. Wong, E. Tracy, A. R. Oseroff, and H. Baumann, “Photodynamic therapy mediates immediate loss of cellular responsiveness to cytokines and growth factors,” Cancer Research, vol. 63, no. 13, pp. 3812–3818, 2003. View at Google Scholar · View at Scopus
  9. M. J. Davies, “Singlet oxygen-mediated damage to proteins and its consequences,” Biochemical and Biophysical Research Communications, vol. 305, no. 3, pp. 761–770, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. N. L. Oleinick and H. H. Evans, “The photobiology of photodynamic therapy: cellular targets and mechanisms,” Radiation Research, vol. 150, no. 5, pp. S146–S156, 1998. View at Google Scholar · View at Scopus
  11. B. W. Henderson and S. O. Gollnick, “Mechanistic principles of photodynamic therapy,” in CRC Handbook of Organic Photochemistry and Photobiology, W. Horspool and F. Lenci, Eds., pp. 145-2–145-25, CRC Press, New York, NY, USA, 2003. View at Google Scholar
  12. L.-Y. Xue, S.-M. Chiu, and N. L. Oleinick, “Photochemical destruction of the Bcl-2 oncoprotein during photodynamic therapy with the phthalocyanine photosensitizer Pc 4,” Oncogene, vol. 20, no. 26, pp. 3420–3427, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. B. W. Henderson, C. Daroqui, E. Tracy et al., “Cross-linking of signal transducer and activator of transcription 3 - A molecular marker for the photodynamic reaction in cells and tumors,” Clinical Cancer Research, vol. 13, no. 11, pp. 3156–3163, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. L.-Y. Xue, S.-M. Chiu, A. Fiebig, D. W. Andrews, and N. L. Oleinick, “Photodamage to multiple Bcl-xL isoforms by photodynamic therapy with the phthalocyanine photosensitizer Pc 4,” Oncogene, vol. 22, no. 58, pp. 9197–9204, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. H.-R. C. Kim, Y. Luo, G. Li, and D. Kessel, “Enhanced apoptotic response to photodynamic therapy after bcl-2 transfection,” Cancer Research, vol. 59, no. 14, pp. 3429–3432, 1999. View at Google Scholar · View at Scopus
  16. J. Usuda, S.-M. Chiu, E. S. Murphy, M. Lam, A.-L. Nieminen, and N. L. Oleinick, “Domain-dependent photodamage to Bcl-2: a membrane anchorage region is needed to form the target of phthalocyanine photosensitization,” Journal of Biological Chemistry, vol. 278, no. 3, pp. 2021–2029, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Zhang, Z. Ao, A. Seth, and S. F. Schlossman, “A mitochondrial membrane protein defined by a novel monoclonal antibody is preferentially detected in apoptotic cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 11, pp. 6290–6295, 1996. View at Google Scholar
  18. M. S. Ke, L. Y. Xue, D. K. Feyes et al., “Uptake of the silicon phthalocyanine Pc 4 and photodynamic dose-response relationships in A-431 vs. jurkat cells,” Journal of Investigative Dermatology, vol. 119, no. 1, p. 336, 2002. View at Google Scholar
  19. R. Willemze, E. S. Jaffe, G. Burg et al., “WHO-EORTC classification for cutaneous lymphomas,” Blood, vol. 105, no. 10, pp. 3768–3785, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Rappl, J. M. Muche, H. Abken et al., “CD4(+)CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sézary syndrome,” Journal of the American Academy of Dermatology, vol. 44, no. 3, pp. 456–461, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. S. R. Stevens, E. D. Baron, S. Masten, and K. D. Cooper, “Circulating CD4+CD7- lymphocyte burden and rapidity of response: predictors of outcome in the treatment of sézary syndrome and erythrodermic mycosis fungoides with extracorporeal photopheresis,” Archives of Dermatology, vol. 138, no. 10, pp. 1347–1350, 2002. View at Google Scholar · View at Scopus
  22. H. Sugiyama, R. Gyulai, E. Toichi et al., “Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation,” Journal of Immunology, vol. 174, no. 1, pp. 164–173, 2005. View at Google Scholar · View at Scopus
  23. R. Dummer, S. A. Michie, D. Kell et al., “Expression of bcl-2 protein and Ki-67 nuclear proliferation antigen in benign and malignant cutaneous T-cell infiltrates,” Journal of Cutaneous Pathology, vol. 22, no. 1, pp. 11–17, 1995. View at Publisher · View at Google Scholar · View at Scopus
  24. X. Mao, G. Orchard, D. M. Lillington et al., “BCL2 and JUNB abnormalities in primary cutaneous lymphomas,” British Journal of Dermatology, vol. 151, no. 3, pp. 546–556, 2004. View at Publisher · View at Google Scholar · View at Scopus